Caffeine Use in Huntington’s Disease: A Single Center Survey
Open Access
- 18 October 2024
- journal article
- research article
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 14 (1) , 52
Abstract
Background: Anecdotal evidence suggests paradoxical caffeine overuse in individuals with Huntington’s disease (HD). A small retrospective study associated caffeine intake over 190 grams daily to earlier onset of HD symptoms. However, specific data on consumption habits is limited. This study aims to gather pilot data on caffeine use in people with HD, exploring motivations and consequences. Methods: Thirty adults with HD completed a survey on daily caffeine intake, its impact on symptoms, and consumption motivations through multiple-choice and open-ended questions. Descriptive statistics were used to analyze findings and compare them to general population data. Results: Caffeine intake ranged from 0 to 1400.4 mg/day, with a median of 273.2 mg/day and a mean of 382.5 mg/day. Seventy percent of participants with HD consumed more caffeine than the average for their age group in the general population. Additionally, 20% of participants and 38% of family members believed caffeine influenced HD symptoms, primarily anxiety. Discussion: People with HD typically consume more caffeine than the general U.S. population. Contrary to the hypothesis, higher caffeine intake was not associated with significant subjective worsening of HD symptoms. Further research with objective measures and multiple HD centers is necessary to guide screening and counseling on caffeine use in this population. Highlights Participants with Huntington’s disease (HD) had increased caffeine intake compared to the general population, supporting previous anecdotal observations. Anxiety was the most affected HD symptom. Further research using objective measures of symptom burden and including multiple HD centers can help inform screening and counseling regarding caffeine use in this population.Keywords
Funding Information
- Clinical and Translational Science Institute, University of California, Los Angeles (UL1TR001881)
This publication has 17 references indexed in Scilit:
- Intake of caffeine from all sources and reasons for use by college studentsClinical Nutrition, 2019
- Coffee extract and caffeine enhance the heat shock response and promote proteostasis in an HSF-1-dependent manner in Caenorhabditis elegansCell Stress and Chaperones, 2018
- Improvement of mitochondrial NAD+/FAD+-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: Implications in Huntington's diseasePharmacological Reports, 2014
- Beverage caffeine intakes in the U.S.Food and Chemical Toxicology, 2014
- Association between caffeine intake and age at onset in Huntington's diseaseNeurobiology of Disease, 2013
- A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's diseaseNeurobiology of Disease, 2011
- Age at onset in Huntington’s disease: replication study on the associations of ADORA2A, HAP1 and OGG1neurogenetics, 2010
- A genetic variation in the ADORA2A gene modifies age at onset in Huntington's diseaseNeurobiology of Disease, 2009
- Unified Huntington's disease rating scale: Reliability and consistencyMovement Disorders, 1996
- The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disordersJournal of Affective Disorders, 1988